- From: Eric Neumann <eneumann@teranode.com>
- Date: Fri, 29 Jun 2007 15:47:00 -0400
- To: "Forsberg, Kerstin L" <Kerstin.L.Forsberg@astrazeneca.com>, public-hcls-dse@w3.org
Received on Friday, 29 June 2007 19:49:31 UTC
Kerstin, Sorry if I misquoted you-- I recall you saying something about staying "on track", but perhaps the subject was not BioRDF but something else. Do you recall what you may have been referring to ? Eric -----Original Message----- From: Forsberg, Kerstin L [mailto:Kerstin.L.Forsberg@astrazeneca.com] Sent: Fri 6/29/2007 3:17 PM To: Eric Neumann; public-hcls-dse@w3.org Subject: RE: Minutes DSE TC Friday June 29 Hi Eric, I did browse through the minutes and do think you slightly misinterpret my point on on the URI discussions in BioRD: I think Jonathan, Alan, Mathias et al is doing a great job that are fundamental for key applications of the URI best practices they develop, in pharmas such as assigning URI:s in a accurate way to subjects, subjects records, observation records. And I do think they are doing fine without any "need to keep them on track". Cheers Kerstin -----Original Message----- From: public-hcls-dse-request@w3.org [mailto:public-hcls-dse-request@w3.org]On Behalf Of Eric Neumann Sent: 29 juni 2007 15:39 To: public-hcls-dse@w3.org Subject: Minutes DSE TC Friday June 29 http://www.w3.org/2007/06/29-dse1-minutes.html cheers, Eric
Received on Friday, 29 June 2007 19:49:31 UTC